Media OutReach
Uni-Bio Science Group Limited Announces 2024 Annual Results
Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8M First-ever Dividend was HK$0.277 Cents Per Share Strengthening Presence in Osteoporosis, Ophthalmology, and Aesthetic Medical Markets
HONG KONG SAR – EQS Newswire – 27 March 2025 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the “Group”, stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2024 (the “Period”).
Key Accomplishments in 2024
During the Year, the Group achieved a spectrum of accomplishments, for both of its marketed products and innovative biologics. The key highlights include:
1. The Group recorded a 14.1% year-on-year (“YoY”) increase in revenue, reaching approximately HK$553.0 million. With its approval in January 2024 and subsequent launch in March 2024, Bogutai® achieved sales of HK$62.9 million, exceeding initial expectations.
2. Profit for the Year soared by16.8% YoY to approximately HK$82.8 million, marking a historic high. These results reaffirm the Group’s solid market position and its ability to deliver sustainable, high-quality growth as a leading biopharmaceutical company.
3. The board of directors (“Board”) has declared a dividend payment for 2024 of HK$0.277 cents per share, marking the historic first for the Company. This is particularly encouraging, as it represents an important milestone for a research-oriented biopharmaceutical company. The Board is also pleased to announce the approval and adoption of a dividend payout policy of no less than 20% of its net profit for the current year.
4. In January 2024, the China National Medical Products Administration (“NMPA”) officially approved the launch of Bogutai®, marking a major breakthrough for the Group in osteoporosis and orthopedic disease management. Since its market debut in early 2024, Bogutai® has gained remarkable traction, achieving a patient retention rate exceeding 70%.
5. In December 2024, the Group successful launch its self-developed medical aesthetics product, 肌顏態®. The recombinant collagen dressing, developed in collaboration with Chongqing Minji Medical Device Co., Ltd., received Class II medical device approval, reinforcing the Group’s commitment to innovative skin repair solutions.
6. In January 2024, the NMPA officially accepted the marketing application for Diquafosol Sodium eye drops, marking a key milestone in the Group’s ophthalmology drug pipeline. During the Year, the Group has already submitted additional data to the Center for Drug Evaluation (CDE). Diquafosol Sodium is expected to receive the marketing approval in the first half of 2025.
7. During the Year, the Group completed the pharmaceutical research and pre-Bioequivalence studies of Esaconazole sulfoate capsules. The formal Bioequivalence trials has been initiated in 2025 to accelerate the launch process.
8. In May 2024, the Group cooperated with Great Bay Bio (GBB) and Pebble Accelerator, a subsidiary of Tigermed to joint development of innovative weight reduction drugs, aiming to revolutionize the treatment of obesity. Through this collaboration, we seek to establish a comprehensive ecological industry chain, spanning from target discovery to antibody generation, druggability verification, process development, clinical pipeline, and ultimately, commercialization.
Annual Results
In 2024, the Group recorded a revenue of approximately HK$553.0 million, representing an increase of 14.1% YoY. The increase in revenue was mainly attributable to the favorable sales performance of the Group’s newly launched product Bogutai®. The Group’s newly launched product Bogutai® achieved sales of HK$62.9 million, exceeding initial expectations. Pinup® recorded a decrease of 2.9% in revenue from approximately HK$247.4 million to approximately HK$240.3 million for the Year. During the Year, the Group was re-selected for the centralized procurement, with a validity period of two years. However, the Group adopted a more selective approach to supplying hospitals in response to certain local policy adjustments. During the Year, revenue generated from GeneTime® was approximately HK$197.9 million, representing an increase of 6.7% YoY. The increase was attributed to the expansion of the Group’s hospital network and additional sales channels beyond hospitals, such as pharmacies and e-commerce platforms. GeneSoft® recorded an increase in revenue from approximately HK$41.3 million to approximately HK$42.5 million, representing an increase of 2.9% YoY. Revenue from Boshutai® declined from approximately HK$10.4 million to approximately HK$9.4 million, representing a decrease of 10.2%. During the Year, Boshutai® was successfully included in the centralized procurement by the Henan Seventeen Provinces Alliance and the procurement validity period is set for two years, which secured the Group with new in-hospital orders.
Prospects
Recent advancements in biotechnology, coupled with strong government support, position China’s pharmaceutical landscape for substantial growth, with a projected compound annual growth rate (CAGR) of 7.5% from 2024 to 2032, according to the IMARC Group. This expansion is driven by technological innovations and a growing elderly population increasingly susceptible to chronic conditions such as diabetes, which boosts pharmaceutical demand. Concurrently, the aesthetic medical sector is emerging as a significant market force, with forecasts indicating a CAGR of 10% to 15% from 2024 to 2027, primarily fueled by rising beauty standards and increased spending among individuals with moderate to high incomes. With the two industries being the Group’s core R&D focuses going forward, it showcases a great potential for the Group to rapidly grow and capture the market shares.
Mr. Kingsley Leung, Chairman of Uni-Bio Science commented, “I am proud to announce that we have reached significant milestones this year, both financially and operationally. As our efforts begin to bear fruit, I am deeply grateful for the unwavering, long-term support of our shareholders. In recognition of this, I am delighted to share two landmark decisions: the declaration of our inaugural dividend and the establishment of a forward-looking dividend payout policy of no less than 20% of its net profit for the current year. These actions reaffirm our steadfast commitment to delivering on our objectives while creating and sustaining value for our shareholders.
Looking forward, we remain steadfast in our commitment to innovation and seizing opportunities within both the pharmaceutical and aesthetic medical sectors. Our vision has consistently focused on diversifying our product offerings while leveraging our strengths in endocrinology, ophthalmology, and dermatology. We are delighted to announce the successful launch of Bogutai® Following this milestone, we will continue to develop best-in-class products, including a PTH microneedle formulation that is less invasive and offers higher bioavailability, as well as a novel antibody drug for weight loss. Significant advancements have also been made in our series of EGF products. Preparations for pilot plant testing of the EGF hydrogel are underway, and Diquafosol Sodium Eye Drop slated for launch in the second quarter of 2025. Additionally, The formal Bioequivalence trials for Esaconazole sulfoate capsules has been initiated in 2025 to accelerate the launch process.
In the aesthetic medical segment, we are excited about the launch of肌顏態® in late December 2024. Building on this momentum, we will accelerate the introduction of other new product lines in 2025 based on Skbrella™ FN. Additionally, we plan to introduce collagen and beauty peptides as advanced skincare raw materials this year. By leveraging our expertise in GeneTime® and 肌顏態®, we aim to create a comprehensive skincare solution for emergency skin repair and stabilization. To foster our product innovation, we are utilizing two new key technology platforms: advanced synthetic biology platform and hydrogel technology. These platforms are expected to drive our product expansion.
To enhance our reach and support product launches, we are expanding our sales channels beyond traditional public and private hospital networks to include pharmacies, online platforms, and aesthetic medical institutions. We are also exploring international markets to bolster our global presence. By adopting a diversified distribution strategy, the Group aims to secure future sales growth while reducing its dependence on regional markets and traditional channels. In support of our company’s growth, the infrastructure for our new factory in Dongguan was fully completed in 2024, marking a significant milestone in our expansion plans. A state-of-the-art BFS packaging line has also been featured, which we believe will enable the Group to command a premium in the market. With these strategic focuses and our commitment to rapid advancement, the Group is well-positioned to solidify its leadership in these dynamic industries and achieve lasting success in the years ahead.”
Hashtag: #Uni-BioScience
The issuer is solely responsible for the content of this announcement.
About Uni-Bio Science Group Limited
Uni-Bio Science Group Limited is principally engaged in the research and development, manufacture and sales of pharmaceutical products. The research and development center is fully equipped with a complete system for the development of genetically-engineered products with a pilot plant test base which is in line with NMPA requirements. The Group also has three GMP manufacturing bases in Beijing, Dongguan and Shenzhen. The Group also has a highly efficient commercialization platform and marketing network. The Group focuses on the development of novel treatments and innovative drugs addressing the therapeutic areas of endocrine such as diabetes and osteoporosis, ophthalmology and dermatology.
Uni-Bio Science Group Limited was listed on the Main Board of the Hong Kong Stock Exchange on November 12, 2001. Stock code: 0690.
For further information, please contact: [email protected]
Hardware Built for Local Conditions
The company isn’t just showing off standard gear; they’ve brought systems specifically designed to handle the challenges of the local energy landscape.
- PowerX1 Hybrid Inverters: Intelligent energy management, seamlessly switching between solar, battery, and grid for stable, uninterrupted power. Supports multi-source integration and rapid power transition.
- Powerinfi All-in-one ESS: ISO 13849 PL-d and IEC 62443 certified for functional safety and cybersecurity. Features a multi-layer battery safety system within a compact design.
- Advanced Solar & System Protection: Incorporates N-type HOT3.0 solar cell technology for enhanced low-light performance. The system boasts an IP66 rating for superior dust and water resistance.
A New Partnership with MIA Group
The big news from the show floor is the new Annual Channel Distribution Strategic Partnership with MIA Group. MIA Group is already a household name in Pakistan for HVAC and energy, and this deal means they’ll be the main bridge for Midea Hiconics’ tech to reach the local market.
“We’re excited to get to work with MIA Group,” a Midea Hiconics spokesperson said. “They have the reach and the local knowledge we need. By putting our hardware in their hands, we’re making it much easier for people here to switch to reliable, clean energy without the usual headaches.”
Media Contact:
Midea Hiconics Press Office
Website: https://www.hiconics-global.com/
Location: Solar Pakistan 2026, Booth A-3-8
Hashtag: #MideaHiconics
The issuer is solely responsible for the content of this announcement.
About Midea Hiconics
Midea Hiconics (SHE: 300048) has been around since 2003 and joined the Midea Group in 2020. They focus on green energy, home storage, and industrial tech, building smart tools that help people take control of their own power.
Check out https://www.hiconics-global.com/ for more info.
Media OutReach
Green SM And Umoney Partner To Build An Integrated Mobility And Digital Finance Ecosystem In Laos
Under the agreement, Umoney will be integrated as a direct payment method within the Green SM app. The two parties will also implement an embedded integration model enabling Umoney users to seamlessly access Green SM’s mobility services directly within the Umoney platform.
For the first time in Laos, customers will experience a fully seamless ride-hailing journey with fares processed instantly via the Umoney e-wallet upon trip completion, replacing the previously common manual bank transfer method. Users simply link their Umoney wallet to the Green SM app for fast, convenient, and fully cashless transactions. Additionally, customers using partner banking applications can pay drivers through Umoney’s QR system, delivering a flexible, fast, and secure payment experience that enhances user convenience and broadens customer reach across both platforms.
As part of the collaboration, Green SM Laos will provide comprehensive mobility solutions for Umoney’s enterprise partners and individual customers, including Green SM Car electric ride-hailing, Green SM Limo, Green SM Airport transfer services, as well as corporate travel packages and flexible, customized mobility plans. Umoney, in turn, will collaborate with Green SM to develop digital financial and payment solutions tailored for drivers within the Green SM ecosystem, encompassing e-wallet services, direct income disbursement, operational expense payments, and cash flow management tools. This synergy is designed to optimize operational efficiency while enhancing the experience for businesses, drivers, and end-users alike.
Beyond mobility and payment solutions, both parties plan to expand their shared digital services ecosystem by integrating Umoney and Unitel’s telecommunications and digital utilities into the Green SM platform, including SIM card registration, mobile top-ups, data package purchases, and other digital services, thereby enhancing the value proposition for users across both platforms.
The two companies will also jointly roll out customer benefit programs targeting Umoney users in Laos, with a particular focus on airports, transaction points, and key high-traffic locations. Through integrated service offerings and incentives promoting electric mobility, Green SM and Umoney aim to foster environmentally responsible travel habits while delivering greater value to customers within their shared ecosystem.
Mr. Ha Chien Thang, Director of Star Fintech Sole Co., Ltd, shared:”Our partnership with Green SM marks a significant milestone in Umoney’s strategy to develop a comprehensive digital finance ecosystem in Laos. The integration of payment capabilities and digital services not only enhances user convenience but also contributes to the advancement of cashless payments and the broader digital transformation of the economy.”
Ms. Tran Hanh An, Director of Mobility Services Sales at Green SM Vietnam & Laos, stated: “The partnership between Umoney and Green SM reflects a shared commitment to connecting the essential infrastructures of modern urban life, from digital finance and telecommunications to a green mobility ecosystem. Through this collaboration, we aim to expand benefits for our customers and driver community while driving meaningful green transformation that is firmly grounded in everyday mobility and consumption needs.”
Furthermore, Green SM and Umoney will collaborate on multi-channel communications initiatives to strengthen brand awareness and expand their combined customer base. Planned activities include co-branded campaigns, promotional programs for new users, digital platform communications, and on-ground experiential activations in key markets.
The partnership between Green SM and Umoney marks a significant convergence of two leading ecosystems in green mobility and digital finance in Laos, united in their pursuit of integrated service solutions that meet the increasingly diverse demands of modern urban life. This collaboration also represents a pivotal step toward fostering innovation, elevating the user experience, and contributing to the sustainable growth of the digital economy in Laos.
Hashtag: #GreenSM
The issuer is solely responsible for the content of this announcement.
Global Leaders Converge to Shape the Future of Higher Education in Asia
HONG KONG SAR – Media OutReach Newswire – 24 April 2026 – The Hong Kong University of Science and Technology (HKUST) and Times Higher Education (THE) co-hosted the Asia Universities Summit 2026 from April 22 to 24. Under the theme “Igniting Global Transformation: Asia’s Leadership,” the three-day premier event explores Asia’s pivotal role in reshaping global innovation and addressing pressing societal challenges through higher education.
The Summit holds particular significance as it coincides with HKUST’s 35th anniversary and marks a decade of partnership between the University and THE since the inaugural summit. This year’s event has attracted over 600 university presidents, policymakers, and industry titans from 25 countries and regions, underscoring a collective commitment to advancing the academic landscape across the continent.
The Summit officially commenced on April 22 at HKUST’s Shaw Auditorium, with the opening ceremony officiated by Dr. SZE Chun-Fai, Jeff, Acting Secretary for Education of the Hong Kong Special Administrative Region (HKSAR) Government; Prof. Nancy IP, President of HKUST; Phil BATY, Chief Global Affairs Officer, and Mei Mei LIM, President, Asia Pacific, from THE.
In her opening remarks, President Ip underscored the need for cross-border collaboration and the evolving role of universities in a rapidly changing world. She said, “As HKUST celebrates its anniversary and a decade of partnership with Times Higher Education, we gather at a defining moment for our region. Asia is increasingly shaping the direction of global innovation, talent development, and societal transformation. In this era of rapid technological advancement and constant change—from artificial intelligence to climate resilience—the challenge of progress lies in anticipating needs and shaping solutions, which calls for a fundamental rethinking of how universities lead. At HKUST, we firmly believe that no single institution can address these global challenges alone; progress will come through openness, partnership, and shared responsibility.
Hong Kong is unique in being the only city in the world with five universities ranked among the global top 100, underscoring its role as a leading international hub for exchange and innovation. Building on this strength, HKUST has initiated dialogues with the world’s leading universities and invited them to Hong Kong to explore opportunities for a university town. This Summit reflects our long‑standing commitment to bringing institutions together to exchange ideas, build meaningful collaborations, and take collective action. By convening leaders from across Asia and beyond, we aim to turn thoughtful dialogue into real impact for our communities and for society at large.”
Dr. SZE Chun-Fai, Jeff, highlighted Hong Kong’s unique position as an international education hub, stating, “Universities today are not only centers of knowledge creation but also powerful drivers of innovation, resilience, and societal impact. In an era of rapid technological advancement, higher education must translate cutting-edge research into real-world solutions that address global challenges. HKUST exemplifies this excellence and achieves remarkable rankings, with its entrepreneurial story equally unmatched, demonstrating the worldwide impact of its research discoveries. Hong Kong has long served as the world’s super-connector and super-value adder, bridging East and West. Our highly internationalized and diversified post-secondary education system positions us ideally to facilitate this convergence between global academic networks and the opportunities of the Chinese Mainland and the wider region. Education, technology, and talent form a foundational triad for success. By fostering talent attraction, interdisciplinary education, industry-academic partnerships, and research collaborations with our counterparts elsewhere, we are building a vibrant ecosystem that strengthens Hong Kong’s innovation edge, contributing to Asia as well as national development.”
Phil Baty reaffirmed THE’s enduring partnership of trust with HKUST and celebrated Asia’s rising global influence, stating, “A decade ago, right here on this stunning campus, THE launched its first-ever Asia Universities Summit. Today, we are witnessing a tilt in the balance of power in global higher education and research from the West to the East. This extraordinary trajectory is driven by Asia’s booming research productivity and global ambitions. Hong Kong, with five universities now ranked among the world’s top 100, stands at the heart of this transformation—a city which we believe will remain the flagship atop the rising tide across Asia, cementing its position as a world-leading powerhouse. New knowledge creation is not a zero-sum game, as we all gain from the leapfrogging Asian university sector. This Summit is a celebration of your excellence and the glorious diversity of our academic community.”
Following the opening ceremony, President Ip joined Prof. Martin O. BERGÖ, Vice-President of Karolinska Institutet, in a keynote fireside chat on longevity science. The discussion explored how advances in biomedicine, neuroscience, and translational research can extend both lifespan and healthspan, while contributing to resilient and equitable societies. President Ip shared insights from her pioneering neuroscience research, including the University’s efforts to decode the biological basis of healthy aging. She said, “Healthy aging is not just about adding years to life, but adding life to our years. We need a paradigm shift from reactive to proactive care. At HKUST, we are focused on monitoring risks for any diseases early and implementing preventive measures. Longevity science is about extending the ‘healthspan’ and as a university, we have much to offer through our research and collaborations. We are uniquely positioned to contribute to this field.”
A spotlight on the first day was a fireside chat between Prof. Harry SHUM, Chairman of the HKUST Council, and Judson ALTHOFF, CEO of Microsoft’s Commercial Business. The dialogue delved into the transformative power of AI across both industry and academia, discussing how universities can collaborate with global technology leaders to prepare students for an AI‑pervasive world. Emphasis was placed not only on technological capability, but also on trust, critical thinking and mindset change within institutions.
Prof. Shum underscored the importance of embracing AI across disciplines, “For our university, at this time, the number one priority is really a mindset change—to focus on AI for science, engineering, business, humanities, and medicine. AI is already here. We do not have to be afraid of this technology. It is a powerful new tool for us and a wonderful thing that we must learn and master to drive growth and innovation.”
Throughout the Summit, President Ip participated in two leadership meetings with over 15 university presidents and senior leaders from institutions across Asia, engaging in candid, strategy‑focused exchanges on shared regional challenges. One session examined how Asia’s emerging innovation corridors—from the Greater Bay Area to other fast‑growing technology belts—can redefine global technology leadership, with discussions centered on governance models and cross‑border collaboration. Another session focused on shaping next‑generation cities, exploring how universities can align research, talent development and policy engagement to support sustainable urban transformation amid rapid technological and societal change. These high-level dialogues emphasized the need for strategic alignment between academic research and regional development, reinforcing the Summit’s mission to leverage Asian leadership for global transformation through collaborative institutional design and shared expertise.
Across a series of high‑level sessions, HKUST senior leadership played an active role in shaping discussions on inclusive leadership, trusted AI in higher education, research commercialization, climate resilience, and global research collaboration. The sessions examined how universities can strengthen governance frameworks to ensure the responsible and ethical use of AI, while cultivating innovation ecosystems that translate research outcomes into socio-economic impact.
The dialogue also addressed strategies for nurturing entrepreneurship, climate‑proofing rapidly growing cities through interdisciplinary engineering approaches, and sustaining borderless research collaboration amid rising geopolitical and regulatory pressures. Collectively, these contributions highlighted HKUST’s commitment to advancing responsible innovation, international partnership, and university leadership attuned to Asia’s evolving challenges and global responsibilities.
The three-day event concluded with a closing ceremony, cementing new strategic partnerships and a shared vision for the future of higher education in the region.
Download photos here: https://hkust.edu.hk/news/hkust-and-times-higher-education-co-host-asia-universities-summit-2026
Hashtag: #HKUST
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn